Tablet
EXFORGE TAB 5MG/160MG (SPAIN)
Summary
EXFORGE TAB 5MG/160MG (SPAIN) — Tablet containing amlodipine (as besilate), valsartan. Hong Kong Registration No. HK-60453. Certificate Holder: NOVARTIS PHARMACEUTICALS (HK) LIMITED. Date of Registration: 24 Apr, 2011.
Product NameEXFORGE TAB 5MG/160MG (SPAIN)
Registration No.HK-60453
Certificate HolderNOVARTIS PHARMACEUTICALS (HK) LIMITED
Holder AddressSUITES 2303-2308, 23/F, NO.1111, KING'S ROAD, TAI KOO SHING, HONG KONG
Ingredientsamlodipine (as besilate), valsartan
Dosage FormTablet
Legal ClassificationPart 1, Schedule 1 & Schedule 3 Poison
Sale RequirementPrescription only Medicines
Date of Registration24 Apr, 2011
ATC codesC08CA01, C09CA03
ATC Classification
ATC level 1
C Cardiovascular System
All ATC groupsC08, C09
This product contains more than one active ingredient. The ATC groups above describe the ingredients, not a single category for the product as a whole.
本頁為藥物資料查詢工具，並非藥物廣告、推廣或醫療建議。所有資料取自香港特別行政區衞生署藥物辦公室之公開資料，僅供參考；一切以藥物辦公室官方公布為準。 本頁不提供任何療效、適應症或治療用途之陳述。用藥前請諮詢醫生或註冊藥劑師。 本網站遵守香港法例第 231 章《不良廣告（醫藥）條例》之規管。